194 related articles for article (PubMed ID: 22815767)
1. Pharmacological inhibition of microsomal prostaglandin E synthase-1 suppresses epidermal growth factor receptor-mediated tumor growth and angiogenesis.
Finetti F; Terzuoli E; Bocci E; Coletta I; Polenzani L; Mangano G; Alisi MA; Cazzolla N; Giachetti A; Ziche M; Donnini S
PLoS One; 2012; 7(7):e40576. PubMed ID: 22815767
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of hypoxia inducible factor-1alpha by dihydroxyphenylethanol, a product from olive oil, blocks microsomal prostaglandin-E synthase-1/vascular endothelial growth factor expression and reduces tumor angiogenesis.
Terzuoli E; Donnini S; Giachetti A; Iñiguez MA; Fresno M; Melillo G; Ziche M
Clin Cancer Res; 2010 Aug; 16(16):4207-16. PubMed ID: 20682710
[TBL] [Abstract][Full Text] [Related]
3. mPGES-1 in prostate cancer controls stemness and amplifies epidermal growth factor receptor-driven oncogenicity.
Finetti F; Terzuoli E; Giachetti A; Santi R; Villari D; Hanaka H; Radmark O; Ziche M; Donnini S
Endocr Relat Cancer; 2015 Aug; 22(4):665-78. PubMed ID: 26113609
[TBL] [Abstract][Full Text] [Related]
4. EGFR signaling upregulates expression of microsomal prostaglandin E synthase-1 in cancer cells leading to enhanced tumorigenicity.
Donnini S; Finetti F; Terzuoli E; Giachetti A; Iñiguez MA; Hanaka H; Fresno M; Rådmark O; Ziche M
Oncogene; 2012 Jul; 31(29):3457-66. PubMed ID: 22081067
[TBL] [Abstract][Full Text] [Related]
5. Effects of AF3442 [N-(9-ethyl-9H-carbazol-3-yl)-2-(trifluoromethyl)benzamide], a novel inhibitor of human microsomal prostaglandin E synthase-1, on prostanoid biosynthesis in human monocytes in vitro.
Bruno A; Di Francesco L; Coletta I; Mangano G; Alisi MA; Polenzani L; Milanese C; Anzellotti P; Ricciotti E; Dovizio M; Di Francesco A; Tacconelli S; Capone ML; Patrignani P
Biochem Pharmacol; 2010 Apr; 79(7):974-81. PubMed ID: 19925781
[TBL] [Abstract][Full Text] [Related]
6. Microsomal prostaglandin E synthase 1 determines tumor growth in vivo of prostate and lung cancer cells.
Hanaka H; Pawelzik SC; Johnsen JI; Rakonjac M; Terawaki K; Rasmuson A; Sveinbjörnsson B; Schumacher MC; Hamberg M; Samuelsson B; Jakobsson PJ; Kogner P; Rådmark O
Proc Natl Acad Sci U S A; 2009 Nov; 106(44):18757-62. PubMed ID: 19846775
[TBL] [Abstract][Full Text] [Related]
7. Microsomal prostaglandin E synthase-1 deficiency is associated with elevated peroxisome proliferator-activated receptor gamma: regulation by prostaglandin E2 via the phosphatidylinositol 3-kinase and Akt pathway.
Kapoor M; Kojima F; Qian M; Yang L; Crofford LJ
J Biol Chem; 2007 Feb; 282(8):5356-66. PubMed ID: 17186945
[TBL] [Abstract][Full Text] [Related]
8. Tumor cells induce COX-2 and mPGES-1 expression in microvascular endothelial cells mainly by means of IL-1 receptor activation.
Casós K; Siguero L; Fernández-Figueras MT; León X; Sardá MP; Vila L; Camacho M
Microvasc Res; 2011 May; 81(3):261-8. PubMed ID: 21277871
[TBL] [Abstract][Full Text] [Related]
9. Genetic deletion of microsomal prostaglandin E synthase-1 suppresses mouse mammary tumor growth and angiogenesis.
Howe LR; Subbaramaiah K; Kent CV; Zhou XK; Chang SH; Hla T; Jakobsson PJ; Hudis CA; Dannenberg AJ
Prostaglandins Other Lipid Mediat; 2013 Oct; 106():99-105. PubMed ID: 23624019
[TBL] [Abstract][Full Text] [Related]
10. Lipopolysaccharide-induced expression of microsomal prostaglandin E synthase-1 mediates late-phase PGE2 production in bone marrow derived macrophages.
Xiao L; Ornatowska M; Zhao G; Cao H; Yu R; Deng J; Li Y; Zhao Q; Sadikot RT; Christman JW
PLoS One; 2012; 7(11):e50244. PubMed ID: 23226252
[TBL] [Abstract][Full Text] [Related]
11. Linking microsomal prostaglandin E Synthase-1/PGE-2 pathway with miR-15a and -186 expression: Novel mechanism of VEGF modulation in prostate cancer.
Terzuoli E; Donnini S; Finetti F; Nesi G; Villari D; Hanaka H; Radmark O; Giachetti A; Ziche M
Oncotarget; 2016 Jul; 7(28):44350-44364. PubMed ID: 27322147
[TBL] [Abstract][Full Text] [Related]
12. Roles of microsomal prostaglandin E synthase-1 in lung metastasis formation in prostate cancer RM9 cells.
Takahashi R; Amano H; Satoh T; Tabata K; Ikeda M; Kitasato H; Akira S; Iwamura M; Majima M
Biomed Pharmacother; 2014 Feb; 68(1):71-7. PubMed ID: 24291175
[TBL] [Abstract][Full Text] [Related]
13. Myrtucommulone, a natural acylphloroglucinol, inhibits microsomal prostaglandin E(2) synthase-1.
Koeberle A; Pollastro F; Northoff H; Werz O
Br J Pharmacol; 2009 Mar; 156(6):952-61. PubMed ID: 19298395
[TBL] [Abstract][Full Text] [Related]
14. Combination of ciglitazone, a peroxisome proliferator-activated receptor gamma ligand, and cisplatin enhances the inhibition of growth of human ovarian cancers.
Yokoyama Y; Xin B; Shigeto T; Mizunuma H
J Cancer Res Clin Oncol; 2011 Aug; 137(8):1219-28. PubMed ID: 21681689
[TBL] [Abstract][Full Text] [Related]
15. Induction of human microsomal prostaglandin E synthase 1 by activated oncogene RhoA GTPase in A549 human epithelial cancer cells.
Choi HJ; Lee DH; Park SH; Kim J; Do KH; An TJ; Ahn YS; Park CB; Moon Y
Biochem Biophys Res Commun; 2011 Sep; 413(3):448-53. PubMed ID: 21907186
[TBL] [Abstract][Full Text] [Related]
16. Microsomal prostaglandin E synthase-1 and 5-lipoxygenase: potential drug targets in cancer.
Rådmark O; Samuelsson B
J Intern Med; 2010 Jul; 268(1):5-14. PubMed ID: 20497297
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of matrix metalloproteinase-3 and -13 synthesis induced by IL-1beta in chondrocytes from mice lacking microsomal prostaglandin E synthase-1.
Gosset M; Pigenet A; Salvat C; Berenbaum F; Jacques C
J Immunol; 2010 Nov; 185(10):6244-52. PubMed ID: 20943996
[TBL] [Abstract][Full Text] [Related]
18. Cyclooxygenase-2, not microsomal prostaglandin E synthase-1, is the mechanism for interleukin-1β-induced prostaglandin E2 production and inhibition of insulin secretion in pancreatic islets.
Parazzoli S; Harmon JS; Vallerie SN; Zhang T; Zhou H; Robertson RP
J Biol Chem; 2012 Sep; 287(38):32246-53. PubMed ID: 22822059
[TBL] [Abstract][Full Text] [Related]
19. Curcumin suppresses interleukin 1beta-mediated microsomal prostaglandin E synthase 1 by altering early growth response gene 1 and other signaling pathways.
Moon Y; Glasgow WC; Eling TE
J Pharmacol Exp Ther; 2005 Nov; 315(2):788-95. PubMed ID: 16081677
[TBL] [Abstract][Full Text] [Related]
20. Potential role of microsomal prostaglandin E synthase-1 in tumorigenesis.
Kamei D; Murakami M; Nakatani Y; Ishikawa Y; Ishii T; Kudo I
J Biol Chem; 2003 May; 278(21):19396-405. PubMed ID: 12626523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
